|
|
Cerebrospinal fluid markers in multiple sclerosis: an overview |
1 |
AR Massaro & P Tonali
|
Abstract
Full Article (PDF)
|
|
Protein markers of brain damage |
5 |
EJ Thompson & AJE Green
|
Abstract
Full Article (PDF)
|
|
Multiple Sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls |
7 |
S Sivieri,
AM Ferrarini & P Gallo
|
Abstract
Full Article (PDF)
|
|
The cytokine storm in multiple sclerosis |
12 |
Hans Link
|
Abstract
Full Article (PDF)
|
|
Myelin basic protein in cerebrospinal fluid and other body fluids |
16 |
John N Whitaker
|
Abstract
Full Article (PDF)
|
|
Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI |
22 |
Jette L Frederiksen & Christian JM Sindic
|
Abstract
Full Article (PDF)
|
|
Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis |
27 |
G Giovannoni
|
Abstract
Full Article (PDF)
|
|
Identification of peptides binding to IgG in the CSF of Multiple Sclerosis patients |
31 |
I Cortese,
S Capone,
R Tafi,
LME Grimaldi,
A Nicosia & R Cortese
|
Abstract
Full Article (PDF)
|
|
Abnormalities of biogenic amines affecting the metabolism of serotonin and catecholamines |
37 |
Karel JB Lamers & Ron A Wevers
|
Abstract
Full Article (PDF)
|
|
Soluble Intercellular Adhesion Molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system |
39 |
M Trojano,
C Avolio,
M Ruggieri,
F De Robertis,
F Giuliani,
D Paolicelli & P Livrea
|
Abstract
Full Article (PDF)
|
|